• Cadrenal Therapeutics (CVKD) Declines 5.67% as Stock Tests Key Support at $3.00 - Ichimoku Cloud dars.gov.et Tue, 07 Jul 2026 20:31:41 GMT
• cadrenal therapeutics secures private placement to extend runway The Globe and Mail Thu, 02 Jul 2026 21:54:44 GMT
• CADRENAL THERAPEUTICS ANNOUNCES UP TO $8.8 MILLION PRIVATE PLACEMENT PRICED AT-THE-MARKET UNDER NASDAQ RULES webull.com Thu, 02 Jul 2026 09:26:35 GMT
• cadrenal (cvkd) ceo sells 7,400 shares, retains direct and trust stakes Stock Titan Thu, 02 Jul 2026 02:47:26 GMT
• form 4 cadrenal therapeutics inc for: 1 july by investing.com in.investing.com Thu, 02 Jul 2026 02:02:43 GMT
• Cadrenal Therapeutics CEO sells $22,422 in stock By Investing.com Investing.com UK Thu, 02 Jul 2026 01:58:00 GMT
• cadrenal therapeutics secures private placement to extend runway TipRanks Wed, 01 Jul 2026 22:02:36 GMT
• Cadrenal Therapeutics Raises $3.0 Million in Private Placement of Pre-Funded and Common Warrants TradingView Wed, 01 Jul 2026 21:33:01 GMT
• Cadrenal Therapeutics (NASDAQ: CVKD) lines up up to $8.8M via private placement Stock Titan Wed, 01 Jul 2026 21:24:02 GMT
• Cadrenal Therapeutics Enters Upto $8.8 Mln Private Placement To Extend Cash Runway; Stock Down RTTNews Wed, 01 Jul 2026 07:00:00 GMT
• Cadrenal (CVKD) CEO sells 7,400 shares, retains direct and trust stakes Stock Titan Wed, 01 Jul 2026 07:00:00 GMT
• cadrenal raises $3m now, with $5.8m more possible from warrants Stock Titan Wed, 01 Jul 2026 03:25:29 GMT
• Cadrenal Therapeutics Announces $3 Million Private Placement with Potential Additional $5.8 Million from Warrants Quiver Quantitative Wed, 01 Jul 2026 00:10:00 GMT
• Cadrenal Therapeutics raises $3 million in private placement By Investing.com Investing.com UK Wed, 01 Jul 2026 00:06:00 GMT
• cadrenal therapeutics announces up to $8.8 million private placement priced at-the-market under nasdaq rules lincolnjournal.com Wed, 01 Jul 2026 00:00:41 GMT
• Cadrenal Therapeutics raises $3 million in private placement Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Cadrenal Therapeutics Board Member Steven Zelenkofske Resigns Moomoo Tue, 30 Jun 2026 04:18:59 GMT
• Cadrenal Therapeutics Appoints Interim CFO John Sharp Under Master Services Agreement with Lohman & Associates Minichart Mon, 29 Jun 2026 23:41:00 GMT
• Cadrenal Therapeutics, Inc. announced that it expects to receive $3 million in funding marketscreener.com Mon, 29 Jun 2026 22:00:00 GMT
• Cadrenal Therapeutics, Inc. Announces Board and Committee Changes marketscreener.com Mon, 29 Jun 2026 21:19:00 GMT
• Cadrenal Therapeutics (NASDAQ: CVKD) names interim CFO and realigns board classes Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• price to book forward of cadrenal therapeutics, inc. – nasdaq:cvkd TradingView Sat, 27 Jun 2026 06:18:36 GMT
• price to earnings forward of cadrenal therapeutics, inc. – nasdaq:cvkd TradingView Sat, 27 Jun 2026 06:18:33 GMT
• enterprise value to revenue forward of cadrenal therapeutics, inc. – nasdaq:cvkd TradingView Sat, 27 Jun 2026 06:00:31 GMT
• price to sales forward of cadrenal therapeutics, inc. – nasdaq:cvkd TradingView Sat, 27 Jun 2026 05:27:29 GMT
• Enterprise value to EBITDA forward of Cadrenal Therapeutics, Inc. – NASDAQ:CVKD TradingView Sat, 27 Jun 2026 04:56:16 GMT
• Cadrenal Therapeutics (CVKD) CEO Quang Pham sells 11,156 shares under 10b5-1 plan Stock Titan Sat, 27 Jun 2026 01:13:43 GMT
• Form 4 Cadrenal Therapeutics Inc For: 26 June By Investing.com Investing.com Nigeria Sat, 27 Jun 2026 00:56:03 GMT
• Cadrenal therapeutics CEO Pham sells $33,919 in stock By Investing.com Investing.com UK Sat, 27 Jun 2026 00:50:00 GMT
• Cadrenal Therapeutics, Inc. Actuals & Estimates (NASDAQ:CVKD) TradingView Fri, 26 Jun 2026 09:20:42 GMT
• cadrenal therapeutics chairman and ceo pham sells $39,829 in stock. by investing.com Investing.com South Africa Thu, 25 Jun 2026 02:25:05 GMT
• Cadrenal Therapeutics Announces Selection of CAD-1005 Phase GlobeNewswire Wed, 24 Jun 2026 07:00:00 GMT
• Cadrenal’s HIT drug gets late-breaking oral slot at ISTH 2026 Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Cadrenal Therapeutics chairman and CEO Pham sells $39,829 in stock. Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Cadrenal (CVKD) CEO Quang Pham sells 11,444 shares in planned 10b5-1 trades Stock Titan Wed, 24 Jun 2026 07:00:00 GMT
• Cadrenal’s HIT drug data selected for presentation at Paris congress Investing.com Wed, 24 Jun 2026 07:00:00 GMT
• Form 4 Cadrenal Therapeutics Inc For: 24 June By Investing.com Investing.com UK Wed, 24 Jun 2026 07:00:00 GMT
• cadrenal therapeutics inc (cvkd) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Cadrenal plans FDA rare pediatric disease request for tecarfarin in Kawasaki disease Contemporary Pediatrics Fri, 19 Jun 2026 07:00:00 GMT
• cadrenal ceo pham sells $13,110 in company stock by investing.com Investing.com Canada Fri, 19 Jun 2026 00:14:19 GMT
• Cadrenal Therapeutics (CVKD) Pursues FDA Designation for Pediatric Treatment GuruFocus Thu, 18 Jun 2026 22:11:31 GMT
• what date does cadrenal therapeutics, inc.'s (cvkd) report earnings - earnings calendar & announcement Zacks Investment Research Thu, 18 Jun 2026 19:59:00 GMT
• cadrenal therapeutics inc (cvkd) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 09:20:00 GMT
• cadrenal therapeutics inc (cvkd) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:19:42 GMT
• cadrenal therapeutics inc (cvkd) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 09:04:33 GMT
• cadrenal therapeutics inc (cvkd) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 08:56:05 GMT
• Cadrenal Therapeutics to File for FDA Rare Pediatric Disease Designation for Tecarfarin in Kawasaki Disease GlobeNewswire Thu, 18 Jun 2026 07:00:00 GMT
• Cadrenal targets FDA rare pediatric status for tecarfarin in Kawasaki disease Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Cadrenal (CVKD) CEO Pham sells 4,126 shares, retains large stake via trust Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Cadrenal plans rare pediatric disease designation for tecarfarin Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Cadrenal CEO Pham sells $13,110 in company stock By Investing.com Investing.com Nigeria Thu, 18 Jun 2026 07:00:00 GMT
• pediatric voucher play: cadrenal (nasdaq: cvkd) eyes tecarfarin rpdd Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• cadrenal therapeutics inc (cvkd) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 22:41:33 GMT
• cadrenal therapeutics inc (cvkd) institutional confidence TradingKey Wed, 17 Jun 2026 21:52:24 GMT
• cadrenal therapeutics inc (cvkd) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 16:56:59 GMT
• cadrenal therapeutics inc (cvkd) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 16:53:32 GMT
• cadrenal therapeutics inc (cvkd) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 16:49:10 GMT
• analysts offer insights on healthcare companies: cadrenal therapeutics, inc. (cvkd) and ideaya biosciences (idya) The Globe and Mail Wed, 17 Jun 2026 07:00:00 GMT
• cadrenal therapeutics inc (cvkd) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• cadrenal therapeutics chairman, ceo pham sells $70,351 in shares by investing.com Investing.com South Africa Tue, 16 Jun 2026 02:04:25 GMT
• cadrenal (cvkd) ceo sells shares under rule 10b5-1 trading plan Stock Titan Tue, 16 Jun 2026 01:21:50 GMT
• cvkd (nasdaq: cvkd) form 144 lists quang x. pham sales of common stock Stock Titan Tue, 16 Jun 2026 00:23:29 GMT
• Cadrenal Therapeutics Advances Multi-Indication Strategy for CAD-1005; Launches Phase 2a Acute Kidney Injury (CSA-AKI) Clinical Pl... GlobeNewswire Mon, 15 Jun 2026 07:00:00 GMT
• New trial targets kidney injury after heart surgery in $1B market Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Cadrenal (CVKD) CEO sells shares under Rule 10b5-1 trading plan Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• CVKD (NASDAQ: CVKD) Form 144 lists Quang X. Pham sales of common stock Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• cadrenal therapeutics chairman, ceo pham sells $70,351 in shares Investing.com Mon, 15 Jun 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) slips 8% amid selling pressure, testing key support levels - put call ratio newsline.com Mon, 15 Jun 2026 02:34:00 GMT
• cadrenal therapeutics (cvkd) slips 8% amid selling pressure, testing key support levels - algorithmic stock picks dars.gov.et Sun, 14 Jun 2026 07:00:00 GMT
• cvkd q1 2026 earnings: narrower-than-expected loss provides temporary relief - net income trends newsline.com Sun, 14 Jun 2026 02:46:05 GMT
• CVKD Q1 2026 Earnings: Narrower-Than-Expected Loss Provides Temporary Relief - Earnings Call Q&A dars.gov.et Sat, 13 Jun 2026 07:00:00 GMT
• cvkd q1 2026 earnings: eps beats estimates despite pre-revenue stage - dividend growth analysis newsline.com Fri, 12 Jun 2026 12:32:31 GMT
• cadrenal therapeutics ceo pham sells $93,293 in common stock by investing.com Investing.com South Africa Thu, 11 Jun 2026 01:53:46 GMT
• cadrenal (nasdaq: cvkd) ceo sells 22,385 shares but keeps large stake Stock Titan Thu, 11 Jun 2026 00:44:40 GMT
• Cadrenal (NASDAQ: CVKD) CEO sells 22,385 shares but keeps large stake Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• cadrenal therapeutics ceo pham sells $93,293 in common stock Investing.com Wed, 10 Jun 2026 07:00:00 GMT
• cvkd q1 2026 earnings: narrower-than-expected loss as company advances rare disease pipeline - earnings season preview newsline.com Tue, 09 Jun 2026 23:47:21 GMT
• Cadrenal Therapeutics CEO Quang Pham sells $36,209 in stock Investing.com Fri, 05 Jun 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) ceo sells 8,285 shares in planned trades Stock Titan Fri, 05 Jun 2026 07:00:00 GMT
• cvkd technical analysis | trend, signals & chart patterns | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 05 Jun 2026 07:00:00 GMT
• cadrenal therapeutics announces cfo transition and interim appointment The Globe and Mail Thu, 04 Jun 2026 21:28:00 GMT
• cadrenal therapeutics q1 2026 earnings: eps beat narrows loss as pre‑revenue biotech advances pipeline - net income trends newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• according to the latest filing with the u.s. securities and exchange commission (sec), cadrenal therapeutics, inc. has officially ... Bitget Thu, 04 Jun 2026 00:24:58 GMT
• cadrenal therapeutics announces cfo transition and interim appointment TipRanks Wed, 03 Jun 2026 21:31:48 GMT
• Cadrenal’s CAD-1005, a HIT clot drug, targets $2B market as Phase 3 looms Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Cadrenal Therapeutics to Showcase Phase 3-Ready CAD-1005 GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• Cadrenal (NASDAQ: CVKD) CFO exits as CEO takes interim finance role Stock Titan Wed, 03 Jun 2026 07:00:00 GMT
• Cadrenal Therapeutics Showcases Phase 3-Ready CAD-1005 And Novel 12-LOX Platform At BIO International Convention 2026 Partnering E... marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• cadrenal therapeutics says matthew szot steps down as cfo - sec filing TradingView Wed, 03 Jun 2026 07:00:00 GMT
• cadrenal therapeutics, inc. announces cfo changes, effective may 28, 2026 marketscreener.com Wed, 03 Jun 2026 07:00:00 GMT
• according to the latest filing with the u.s. securities and exchange commission (sec), cadrenal therapeutics, inc. has officially ... Bitget Wed, 03 Jun 2026 05:35:38 GMT
• cadrenal therapeutics ceo pham sells $3,074 in common stock by investing.com Investing.com South Africa Wed, 03 Jun 2026 02:02:59 GMT
• cadrenal therapeutics (cvkd) ceo logs 652-share rule 10b5-1 stock sale Stock Titan Wed, 03 Jun 2026 00:36:56 GMT
• cadrenal therapeutics (cvkd) ceo logs 652-share rule 10b5-1 stock sale Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• cadrenal therapeutics ceo pham sells $3,074 in common stock Investing.com Tue, 02 Jun 2026 07:00:00 GMT
• cvkd q1 2026 earnings: eps beat with 37% surprise; stock declines slightly - return on capital newsline.com Mon, 01 Jun 2026 07:00:00 GMT
• cvkd q1 2026 earnings: narrower eps loss surprises as development pipeline advances - profit announcement The Legal Advocate Fri, 29 May 2026 23:35:31 GMT
• cadrenal (cvkd) ceo sells 12,763 shares, retains direct and trust holdings Stock Titan Fri, 29 May 2026 07:00:00 GMT
• cvkd stock price, quote & chart | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 29 May 2026 07:00:00 GMT
• cvkd technical analysis | trend, signals & chart patterns | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 29 May 2026 07:00:00 GMT
• cadrenal therapeutics q1 2026 earnings: narrowed loss surpasses estimates, stock edges higher - eps growth rate thelegaladvocate.com Thu, 28 May 2026 21:33:33 GMT
• cvkd: cad-1005 targets hit at its immune root, aiming to transform outcomes and reduce costs TradingView Thu, 28 May 2026 13:53:23 GMT
• CVKD: CAD-1005 offers a novel, upstream approach to HIT, aiming to improve outcomes and reduce costs TradingView Thu, 28 May 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) holds steady, consolidating between support and resistance - gap up stocks The Legal Advocate Wed, 27 May 2026 14:32:43 GMT
• cadrenal therapeutics ceo pham sells $6,628 in company stock by investing.com Investing.com UK Wed, 27 May 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) slides 5.2% as support level comes into focus - leading diagonal newsline.com Wed, 27 May 2026 07:00:00 GMT
• cvkd q1 2026 earnings: narrower-than-expected loss as pre-revenue biotech advances pipeline - guidance accuracy score newsline.com Wed, 27 May 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) ceo quang pham sells 1,165 shares in pre-planned trade Stock Titan Wed, 27 May 2026 01:13:07 GMT
• cadrenal therapeutics ceo pham sells $6,628 in company stock Investing.com Tue, 26 May 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) ceo quang pham sells 1,165 shares in pre-planned trade Stock Titan Tue, 26 May 2026 07:00:00 GMT
• cadrenal therapeutics (cvkd) holds steady above support as traders eye resistance at $5.45 - skew index newsline.com Mon, 25 May 2026 07:00:00 GMT
• cvkd q1 2026 earnings: narrowing losses and steady progress in clinical pipeline - downward estimate revision lwvtexas.org Fri, 22 May 2026 07:00:00 GMT
• cvkd stock price, quote & chart | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 22 May 2026 07:00:00 GMT
• cvkd technical analysis | trend, signals & chart patterns | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 22 May 2026 07:00:00 GMT
• cvkd technical analysis | trend, signals & chart patterns | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Thu, 21 May 2026 07:00:00 GMT
• cvkd stock price, quote & chart | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Thu, 21 May 2026 07:00:00 GMT
• cvkd stock price, quote & chart | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Wed, 20 May 2026 07:00:00 GMT
• Cadrenal Therapeutics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 GlobeNewswire Tue, 19 May 2026 07:00:00 GMT
• cadrenal therapeutics to present at lytham partners spring 2026 investor conference on may 28 Pluang Tue, 19 May 2026 07:00:00 GMT
• (cvkd) and the role of price-sensitive allocations Stock Traders Daily Mon, 18 May 2026 07:00:00 GMT
• number of shareholders of cadrenal therapeutics, inc. – nasdaq:cvkd TradingView Sun, 17 May 2026 08:25:24 GMT
• cvkd stock price, quote & chart | cadrenal therapeutics inc (nasdaq:cvkd) ChartMill Fri, 15 May 2026 07:00:00 GMT
• cvkd stock retail sentiment peaks after fda clears phase 3 path for blood clot drug MSN Thu, 14 May 2026 12:09:26 GMT
• cvkd stock retail sentiment peaks after fda clears phase 3 path for blood clot drug MSN Wed, 13 May 2026 12:16:47 GMT
• cvkd stock retail sentiment peaks after fda clears phase 3 path for blood clot drug MSN Sat, 09 May 2026 01:21:01 GMT
• cvkd stock retail sentiment peaks after fda clears phase 3 path for blood clot drug MSN Fri, 08 May 2026 16:03:39 GMT
• cvkd stock retail sentiment peaks after fda clears phase 3 path for blood clot drug MSN Thu, 07 May 2026 19:18:29 GMT
• cadrenal therapeutics, inc. released its financial results for the first quarter of 2026 and provided updates on the phase iii cli... Bitget Thu, 07 May 2026 12:41:57 GMT
• cadrenal therapeutics, inc. 1q 2026: net income $(2.50m), eps $(1.04) — 10-q summary TradingView Thu, 07 May 2026 12:41:00 GMT
• Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following E... GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• Cadrenal targets 120-patient global Phase 3 trial for HIT drug Stock Titan Thu, 07 May 2026 07:00:00 GMT
• cash strain and nasdaq equity risk for cadrenal (nasdaq: cvkd) Stock Titan Thu, 07 May 2026 07:00:00 GMT
Cadrenal Therapeutics(NASDAQ:CVKD) 
Cadrenal Therapeutics, Inc. operates as a clinical development biopharmaceutical company. The company focuses on developing Tecarfarin, a novel therapy with orphan drug indication for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fib...
Website: https://www.cadrenal.com/
Founded: 2022
IPO Price: $5 (Jan 20, 2023)
Full Time Employees: 1
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends